How Do Employers Qualitatively Keep Pace in a Sea of Embellished Resumes? A recent Financial Times article estimates that around half of job applicants are now consistently using AI tools, such as ChatGPT and Gemini, to apply for roles. This statistic is staggering,...
How HR and hiring managers can improve interview outcomes to find objectively good scientific talent. It’s Tuesday morning. As the hiring manager for your biopharma company, you’re expecting a scientist to show up to an 8:30am interview. You get a call from the front...
This Intelligence Can Be Helpful When Preparing to Make an Offer, But it Can Also Land You in Hot Water. It can be difficult to assess candidates for a role, especially if you don’t know them from a previous job. Some people interview well and some don’t. But either...
With clinical trials failing at least 90% of the time, here are current trends in the industry’s investment and hiring front. Clinical drug development is notoriously difficult. It is expensive, takes over a decade, and has an extremely high rate of failure—90% or...
An examination of the evolving state of interviewing within the biotech industry of 2024. Like so many other aspects of the biotech industry, talent acquisition within the field has undergone a transformation in the last few years. With the pandemic-driven rise in...
Will the Trump Administration Create More Headwinds for the Biopharma Sector? What’s in store? Donald Trump’s return to the presidency has the potential to bring significant changes to U.S. health care policy. His administration promised to empower figures like...
Structured interviews and setting aside first impressions can help biotech hiring managers uncover talented but reserved candidates, ensuring strong scientists aren't overlooked due to interview style or first impressions. Shifting focus to “screening in” candidates promotes a more accurate assessment of both technical and soft skills.
Backdoor references can offer valuable insights into a candidate's skills and work ethic beyond their formal references, but hiring managers must handle them with care to ensure credibility and confidentiality. These informal checks should complement structured interviews rather than serve as the primary assessment tool.
Clinical drug development is costly and has a failure rate over 90%, necessitating significant external funding for small companies. As mergers and acquisitions increase amid fierce competition and patent expirations, ongoing layoffs create opportunities for organizations to acquire talent.
Biotech talent acquisition has increasingly embraced virtual interviews, yet many professionals stress the importance of in-person assessments for cultural fit. A blended approach of virtual and face-to-face interviews, along with behavioral evaluations, is crucial for identifying the best candidates.